IDEXX Laboratories, Inc. (IDXX)
558.32
-14.97
(-2.61%)
USD |
NASDAQ |
Mar 27, 16:00
555.48
-2.84
(-0.51%)
After-Hours: 20:00
IDEXX Laboratories EPS Diluted (Quarterly) : 3.084 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| Intuitive Surgical, Inc. | 2.205 |
| Merck & Co., Inc. | 1.191 |
| Pfizer Inc. | -0.2898 |
| Biogen, Inc. | -0.3333 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 248.19M |
| Revenue (Quarterly) | 1.091B |
| Total Expenses (Quarterly) | 842.39M |
| Enterprise Value | 45.25B |
| Gross Profit Margin (Quarterly) | 60.47% |
| Profit Margin (Quarterly) | 22.76% |
| Earnings Yield | 2.34% |
| Operating Earnings Yield | 3.02% |
| Normalized Earnings Yield | 2.338 |